# Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation

> **NCT02177266** · PHASE3 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Atrial Fibrillation
- Post-pericardiotomy Syndrome
- Constriction

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02177266
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulty in recruiting patients
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177266, "Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02177266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*